Altium Capital Management’s ESSA Pharma EPIX Stock Holding History

Altium Capital Management’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,050,369	Closed	-$1.66M	–	5
2025 Q1	$1.66M	Sell	1,050,369 -377,631	-26%	-$639K	4%	9
2024 Q4	$2.56M	Buy	+1,428,000	New	+$4.55M	0.73%	46
2022 Q1	–	Sell	-345,000	Closed	-$4.9M	–	129
2021 Q4	$4.9M	Buy	+345,000	New	+$3.84M	1.35%	25
2021 Q3	–	Sell	-213,528	Closed	-$6.1M	–	132
2021 Q2	$6.1M	Sell	213,528 -16,535	-7%	-$481K	1.41%	14
2021 Q1	$6.68M	Buy	230,063 +54,996	+31%	+$1.28M	1.86%	5
2020 Q4	$2.09M	Buy	+175,067	New	+$1.23M	0.78%	54

Other funds holding EPIX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aldebaran Capital Carmel, Indiana $133M AUM 42.18% 1-Year Est. Return

DAM

DLD Asset Management New York $1.51B AUM 5.32% 1-Year Est. Return

Altium Capital Management's EPIX Position: Q2 2025 in Review

Altium Capital Management sold out of ESSA Pharma (EPIX) in Q2 2025, closing a stake of 1,050,369 shares — an estimated $1.66M sold.

Altium Capital Management first reported a position in EPIX in Q4 2020 and held it in 6 quarters. The position peaked at $6.68M in Q1 2021. 36 funds tracked by Wall St. Rank hold EPIX as of Q2 2025.

Altium Capital Management reported no remaining ESSA Pharma position as of Q2 2025 after selling out during the quarter.
Altium Capital Management sold 1,050,369 ESSA Pharma shares in Q2 2025, an estimated $1.66M.
Altium Capital Management first reported a position in ESSA Pharma in Q4 2020 and held it in 6 quarters.
Altium Capital Management's ESSA Pharma position peaked at $6.68M in Q1 2021.
36 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2025.

Based on Altium Capital Management's 13F filing for Q2 2025.